Platelet	B:C0370220
rich	I:C0370220
plasma	I:C0370220
versus	O
steroid	O
on	O
lateral	O
epicondylitis	I:C0039516
:	O
meta-analysis	O
of	O
randomized	O
clinical	I:C0206034
trials	I:C0206034
.	O

Platelet	O
rich	I:C0370220
plasma	I:C0370220
versus	O
steroid	B:C0038317
on	O
lateral	O
epicondylitis	I:C0039516
:	O
meta-analysis	O
of	O
randomized	O
clinical	I:C0206034
trials	I:C0206034
.	O

Platelet	O
rich	I:C0370220
plasma	I:C0370220
versus	O
steroid	O
on	O
lateral	B:C0039516
epicondylitis	I:C0039516
:	O
meta-analysis	O
of	O
randomized	O
clinical	I:C0206034
trials	I:C0206034
.	O

Platelet	O
rich	I:C0370220
plasma	I:C0370220
versus	O
steroid	O
on	O
lateral	O
epicondylitis	I:C0039516
:	O
meta-analysis	B:C0920317
of	O
randomized	O
clinical	I:C0206034
trials	I:C0206034
.	O

Platelet	O
rich	I:C0370220
plasma	I:C0370220
versus	O
steroid	O
on	O
lateral	O
epicondylitis	I:C0039516
:	O
meta-analysis	O
of	O
randomized	B:C0206034
clinical	I:C0206034
trials	I:C0206034
.	O

Lateral	B:C0039516
epicondylitis	I:C0039516
(	O
Lateral	O
epicondylitis	I:C0039516
)	O
is	O
a	O
common	O
tendinopathy	O
for	O
which	O
an	O
effective	O
treatment	O
is	O
still	O
unknown	O
.	O

Lateral	O
epicondylitis	I:C0039516
(	O
Lateral	B:C0039516
epicondylitis	I:C0039516
)	O
is	O
a	O
common	O
tendinopathy	O
for	O
which	O
an	O
effective	O
treatment	O
is	O
still	O
unknown	O
.	O

Lateral	O
epicondylitis	I:C0039516
(	O
Lateral	O
epicondylitis	I:C0039516
)	O
is	O
a	O
common	O
tendinopathy	B:C1568272
for	O
which	O
an	O
effective	O
treatment	O
is	O
still	O
unknown	O
.	O

Lateral	O
epicondylitis	I:C0039516
(	O
Lateral	O
epicondylitis	I:C0039516
)	O
is	O
a	O
common	O
tendinopathy	O
for	O
which	O
an	O
effective	O
treatment	B:C0087111
is	O
still	O
unknown	O
.	O

The	O
purpose	O
of	O
this	O
meta	B:C0920317
-	I:C0920317
analysis	I:C0920317
was	O
to	O
compare	O
the	O
effectiveness	O
of	O
platelet	O
rich	I:C0370220
plasma	I:C0370220
(	O
platelet	O
rich	I:C0370220
plasma	I:C0370220
)	O
vs	O
steroid	O
in	O
reducing	O
pain	O
and	O
improving	O
function	O
of	O
the	O
elbow	O
in	O
the	O
treatment	O
of	O
Lateral	O
epicondylitis	I:C0039516
.	O

The	O
purpose	O
of	O
this	O
meta	O
-	I:C0920317
analysis	I:C0920317
was	O
to	O
compare	O
the	O
effectiveness	O
of	O
platelet	B:C0370220
rich	I:C0370220
plasma	I:C0370220
(	O
platelet	O
rich	I:C0370220
plasma	I:C0370220
)	O
vs	O
steroid	O
in	O
reducing	O
pain	O
and	O
improving	O
function	O
of	O
the	O
elbow	O
in	O
the	O
treatment	O
of	O
Lateral	O
epicondylitis	I:C0039516
.	O

The	O
purpose	O
of	O
this	O
meta	O
-	I:C0920317
analysis	I:C0920317
was	O
to	O
compare	O
the	O
effectiveness	O
of	O
platelet	O
rich	I:C0370220
plasma	I:C0370220
(	O
platelet	B:C0370220
rich	I:C0370220
plasma	I:C0370220
)	O
vs	O
steroid	O
in	O
reducing	O
pain	O
and	O
improving	O
function	O
of	O
the	O
elbow	O
in	O
the	O
treatment	O
of	O
Lateral	O
epicondylitis	I:C0039516
.	O

The	O
purpose	O
of	O
this	O
meta	O
-	I:C0920317
analysis	I:C0920317
was	O
to	O
compare	O
the	O
effectiveness	O
of	O
platelet	O
rich	I:C0370220
plasma	I:C0370220
(	O
platelet	O
rich	I:C0370220
plasma	I:C0370220
)	O
vs	O
steroid	B:C0038317
in	O
reducing	O
pain	O
and	O
improving	O
function	O
of	O
the	O
elbow	O
in	O
the	O
treatment	O
of	O
Lateral	O
epicondylitis	I:C0039516
.	O

The	O
purpose	O
of	O
this	O
meta	O
-	I:C0920317
analysis	I:C0920317
was	O
to	O
compare	O
the	O
effectiveness	O
of	O
platelet	O
rich	I:C0370220
plasma	I:C0370220
(	O
platelet	O
rich	I:C0370220
plasma	I:C0370220
)	O
vs	O
steroid	O
in	O
reducing	O
pain	B:C0030193
and	O
improving	O
function	O
of	O
the	O
elbow	O
in	O
the	O
treatment	O
of	O
Lateral	O
epicondylitis	I:C0039516
.	O

The	O
purpose	O
of	O
this	O
meta	O
-	I:C0920317
analysis	I:C0920317
was	O
to	O
compare	O
the	O
effectiveness	O
of	O
platelet	O
rich	I:C0370220
plasma	I:C0370220
(	O
platelet	O
rich	I:C0370220
plasma	I:C0370220
)	O
vs	O
steroid	O
in	O
reducing	O
pain	O
and	O
improving	O
function	O
of	O
the	O
elbow	B:C0013769
in	O
the	O
treatment	O
of	O
Lateral	O
epicondylitis	I:C0039516
.	O

The	O
purpose	O
of	O
this	O
meta	O
-	I:C0920317
analysis	I:C0920317
was	O
to	O
compare	O
the	O
effectiveness	O
of	O
platelet	O
rich	I:C0370220
plasma	I:C0370220
(	O
platelet	O
rich	I:C0370220
plasma	I:C0370220
)	O
vs	O
steroid	O
in	O
reducing	O
pain	O
and	O
improving	O
function	O
of	O
the	O
elbow	O
in	O
the	O
treatment	B:C0087111
of	O
Lateral	O
epicondylitis	I:C0039516
.	O

The	O
purpose	O
of	O
this	O
meta	O
-	I:C0920317
analysis	I:C0920317
was	O
to	O
compare	O
the	O
effectiveness	O
of	O
platelet	O
rich	I:C0370220
plasma	I:C0370220
(	O
platelet	O
rich	I:C0370220
plasma	I:C0370220
)	O
vs	O
steroid	O
in	O
reducing	O
pain	O
and	O
improving	O
function	O
of	O
the	O
elbow	O
in	O
the	O
treatment	O
of	O
Lateral	B:C0039516
epicondylitis	I:C0039516
.	O

A	O
systematic	O
search	O
of	O
the	O
literature	B:C0023866
was	O
conducted	O
to	O
identify	O
related	O
articles	O
published	O
from	O
January	O
1980	O
to	O
September	O
2016	O
in	O
Pubmed	O
,	O
Embase	O
,	O
the	O
Cochrane	O
Library	I:C0282574
and	O
SpringerLink	O
.	O

A	O
systematic	O
search	O
of	O
the	O
literature	O
was	O
conducted	O
to	O
identify	O
related	O
articles	B:C1706852
published	O
from	O
January	O
1980	O
to	O
September	O
2016	O
in	O
Pubmed	O
,	O
Embase	O
,	O
the	O
Cochrane	O
Library	I:C0282574
and	O
SpringerLink	O
.	O

A	O
systematic	O
search	O
of	O
the	O
literature	O
was	O
conducted	O
to	O
identify	O
related	O
articles	O
published	O
from	O
January	O
1980	O
to	O
September	O
2016	O
in	O
Pubmed	B:C1138432
,	O
Embase	O
,	O
the	O
Cochrane	O
Library	I:C0282574
and	O
SpringerLink	O
.	O

A	O
systematic	O
search	O
of	O
the	O
literature	O
was	O
conducted	O
to	O
identify	O
related	O
articles	O
published	O
from	O
January	O
1980	O
to	O
September	O
2016	O
in	O
Pubmed	O
,	O
Embase	B:C0282574
,	O
the	O
Cochrane	O
Library	I:C0282574
and	O
SpringerLink	O
.	O

A	O
systematic	O
search	O
of	O
the	O
literature	O
was	O
conducted	O
to	O
identify	O
related	O
articles	O
published	O
from	O
January	O
1980	O
to	O
September	O
2016	O
in	O
Pubmed	O
,	O
Embase	O
,	O
the	O
Cochrane	B:C0282574
Library	I:C0282574
and	O
SpringerLink	O
.	O

A	O
systematic	O
search	O
of	O
the	O
literature	O
was	O
conducted	O
to	O
identify	O
related	O
articles	O
published	O
from	O
January	O
1980	O
to	O
September	O
2016	O
in	O
Pubmed	O
,	O
Embase	O
,	O
the	O
Cochrane	O
Library	I:C0282574
and	O
SpringerLink	B:C0282574
.	O

All	O
studies	B:C2603343
that	O
compared	O
platelet	O
rich	I:C0370220
plasma	I:C0370220
with	O
steroid	O
administration	O
on	O
Lateral	O
epicondylitis	I:C0039516
were	O
included	O
.	O

All	O
studies	O
that	O
compared	O
platelet	B:C0370220
rich	I:C0370220
plasma	I:C0370220
with	O
steroid	O
administration	O
on	O
Lateral	O
epicondylitis	I:C0039516
were	O
included	O
.	O

All	O
studies	O
that	O
compared	O
platelet	O
rich	I:C0370220
plasma	I:C0370220
with	O
steroid	B:C0038317
administration	O
on	O
Lateral	O
epicondylitis	I:C0039516
were	O
included	O
.	O

All	O
studies	O
that	O
compared	O
platelet	O
rich	I:C0370220
plasma	I:C0370220
with	O
steroid	O
administration	O
on	O
Lateral	B:C0039516
epicondylitis	I:C0039516
were	O
included	O
.	O

Main	O
outcomes	O
were	O
collected	O
and	O
analyzed	B:C0936012
by	O
the	O
Review	O
Manager	I:C0037585
5.1	I:C0037585
.	O

Main	O
outcomes	O
were	O
collected	O
and	O
analyzed	O
by	O
the	O
Review	B:C0037585
Manager	I:C0037585
5.1	I:C0037585
.	O

Eight	O
randomized	B:C0206035
controlled	I:C0206035
trials	I:C0206035
(	O
randomized	O
controlled	I:C0206035
trials	I:C0206035
)	O
that	O
involved	O
511	O
patients	O
met	O
the	O
criteria	O
.	O

Eight	O
randomized	O
controlled	I:C0206035
trials	I:C0206035
(	O
randomized	B:C0206035
controlled	I:C0206035
trials	I:C0206035
)	O
that	O
involved	O
511	O
patients	O
met	O
the	O
criteria	O
.	O

This	O
meta	B:C0920317
-	I:C0920317
analysis	I:C0920317
showed	O
that	O
there	O
was	O
no	O
significant	O
difference	O
in	O
pain	O
relief	I:C0451615
in	O
the	O
short	O
-	O
term	O
(	O
2	O
to	O
4	O
weeks	O
:	O
SMD	O
=	O
1.02	O
,	O
P	O
=	O
.03	O
;	O
6	O
to	O
8	O
weeks	O
:	O
SMD	O
=	O
.73	O
,	O
P	O
=	O
.24	O
)	O
and	O
the	O
intermediate	O
-	O
term	O
(	O
12	O
weeks	O
:	O
SMD	O
=	O
-	O
0.28	O
,	O
P	O
=	O
.35	O
)	O
.	O

This	O
meta	O
-	I:C0920317
analysis	I:C0920317
showed	O
that	O
there	O
was	O
no	O
significant	O
difference	O
in	O
pain	B:C0451615
relief	I:C0451615
in	O
the	O
short	O
-	O
term	O
(	O
2	O
to	O
4	O
weeks	O
:	O
SMD	O
=	O
1.02	O
,	O
P	O
=	O
.03	O
;	O
6	O
to	O
8	O
weeks	O
:	O
SMD	O
=	O
.73	O
,	O
P	O
=	O
.24	O
)	O
and	O
the	O
intermediate	O
-	O
term	O
(	O
12	O
weeks	O
:	O
SMD	O
=	O
-	O
0.28	O
,	O
P	O
=	O
.35	O
)	O
.	O

Steroid	B:C0038317
exhibited	O
a	O
better	O
efficacy	O
of	O
function	O
in	O
the	O
short	O
-	O
term	O
(	O
2	O
to	O
4	O
weeks	O
:	O
SMD	O
=	O
.61	O
,	O
P	O
<	O
.001	O
;	O
6	O
to	O
8	O
weeks	O
:	O
SMD	O
=	O
.53	O
,	O
P	O
<	O
.001	O
)	O
.	O

However	O
,	O
platelet	B:C0370220
rich	I:C0370220
plasma	I:C0370220
was	O
superior	O
to	O
steroid	O
for	O
pain	O
relief	I:C0451615
in	O
the	O
long	O
-	O
term	O
(	O
half	O
year	O
:	O
SMD	O
=	O
-	O
1.6	O
,	O
P	O
<	O
.001	O
;	O
one	O
year	O
:	O
SMD	O
=	O
-	O
1.45	O
,	O
P	O
<	O
.001	O
)	O
,	O
and	O
also	O
for	O
function	O
improving	O
in	O
the	O
intermediate	O
-	O
term	O
(	O
12	O
weeks	O
:	O
SMD	O
=	O
-	O
0.53	O
,	O
P	O
<	O
.001	O
)	O
and	O
the	O
long	O
-	O
term	O
(	O
half	O
year	O
:	O
SMD	O
=	O
-	O
0.56	O
,	O
P	O
<	O
.001	O
;	O
one	O
year	O
:	O
SMD	O
=	O
-	O
0.7	O
,	O
P	O
<	O
.001	O
)	O
.	O

However	O
,	O
platelet	O
rich	I:C0370220
plasma	I:C0370220
was	O
superior	O
to	O
steroid	B:C0038317
for	O
pain	O
relief	I:C0451615
in	O
the	O
long	O
-	O
term	O
(	O
half	O
year	O
:	O
SMD	O
=	O
-	O
1.6	O
,	O
P	O
<	O
.001	O
;	O
one	O
year	O
:	O
SMD	O
=	O
-	O
1.45	O
,	O
P	O
<	O
.001	O
)	O
,	O
and	O
also	O
for	O
function	O
improving	O
in	O
the	O
intermediate	O
-	O
term	O
(	O
12	O
weeks	O
:	O
SMD	O
=	O
-	O
0.53	O
,	O
P	O
<	O
.001	O
)	O
and	O
the	O
long	O
-	O
term	O
(	O
half	O
year	O
:	O
SMD	O
=	O
-	O
0.56	O
,	O
P	O
<	O
.001	O
;	O
one	O
year	O
:	O
SMD	O
=	O
-	O
0.7	O
,	O
P	O
<	O
.001	O
)	O
.	O

However	O
,	O
platelet	O
rich	I:C0370220
plasma	I:C0370220
was	O
superior	O
to	O
steroid	O
for	O
pain	B:C0451615
relief	I:C0451615
in	O
the	O
long	O
-	O
term	O
(	O
half	O
year	O
:	O
SMD	O
=	O
-	O
1.6	O
,	O
P	O
<	O
.001	O
;	O
one	O
year	O
:	O
SMD	O
=	O
-	O
1.45	O
,	O
P	O
<	O
.001	O
)	O
,	O
and	O
also	O
for	O
function	O
improving	O
in	O
the	O
intermediate	O
-	O
term	O
(	O
12	O
weeks	O
:	O
SMD	O
=	O
-	O
0.53	O
,	O
P	O
<	O
.001	O
)	O
and	O
the	O
long	O
-	O
term	O
(	O
half	O
year	O
:	O
SMD	O
=	O
-	O
0.56	O
,	O
P	O
<	O
.001	O
;	O
one	O
year	O
:	O
SMD	O
=	O
-	O
0.7	O
,	O
P	O
<	O
.001	O
)	O
.	O

No	O
serious	O
adverse	B:C0879626
effects	I:C0879626
of	O
treatment	O
were	O
observed	O
in	O
the	O
two	O
groups	O
.	O

No	O
serious	O
adverse	O
effects	I:C0879626
of	O
treatment	B:C0087111
were	O
observed	O
in	O
the	O
two	O
groups	O
.	O

Treatment	B:C0087111
of	O
patients	O
with	O
Lateral	O
epicondylitis	I:C0039516
by	O
steroid	O
could	O
slightly	O
relieve	O
pain	I:C0451615
and	O
significantly	O
improve	O
function	O
of	O
elbow	O
in	O
the	O
short	O
-	O
term	O
(	O
2	O
to	O
4	O
weeks	O
,	O
6	O
to	O
8	O
weeks	O
)	O
.	O

Treatment	O
of	O
patients	O
with	O
Lateral	B:C0039516
epicondylitis	I:C0039516
by	O
steroid	O
could	O
slightly	O
relieve	O
pain	I:C0451615
and	O
significantly	O
improve	O
function	O
of	O
elbow	O
in	O
the	O
short	O
-	O
term	O
(	O
2	O
to	O
4	O
weeks	O
,	O
6	O
to	O
8	O
weeks	O
)	O
.	O

Treatment	O
of	O
patients	O
with	O
Lateral	O
epicondylitis	I:C0039516
by	O
steroid	B:C0038317
could	O
slightly	O
relieve	O
pain	I:C0451615
and	O
significantly	O
improve	O
function	O
of	O
elbow	O
in	O
the	O
short	O
-	O
term	O
(	O
2	O
to	O
4	O
weeks	O
,	O
6	O
to	O
8	O
weeks	O
)	O
.	O

Treatment	O
of	O
patients	O
with	O
Lateral	O
epicondylitis	I:C0039516
by	O
steroid	O
could	O
slightly	O
relieve	B:C0451615
pain	I:C0451615
and	O
significantly	O
improve	O
function	O
of	O
elbow	O
in	O
the	O
short	O
-	O
term	O
(	O
2	O
to	O
4	O
weeks	O
,	O
6	O
to	O
8	O
weeks	O
)	O
.	O

Treatment	O
of	O
patients	O
with	O
Lateral	O
epicondylitis	I:C0039516
by	O
steroid	O
could	O
slightly	O
relieve	O
pain	I:C0451615
and	O
significantly	O
improve	O
function	O
of	O
elbow	B:C0013769
in	O
the	O
short	O
-	O
term	O
(	O
2	O
to	O
4	O
weeks	O
,	O
6	O
to	O
8	O
weeks	O
)	O
.	O

platelet	B:C0370220
rich	I:C0370220
plasma	I:C0370220
appears	O
to	O
be	O
more	O
effective	O
in	O
relieving	O
pain	I:C0451615
and	O
improving	O
function	O
in	O
the	O
intermediate	O
-	O
term	O
(	O
12	O
weeks	O
)	O
and	O
long	O
-	O
term	O
(	O
half	O
year	O
and	O
one	O
year	O
)	O
.	O

platelet	O
rich	I:C0370220
plasma	I:C0370220
appears	O
to	O
be	O
more	O
effective	O
in	O
relieving	B:C0451615
pain	I:C0451615
and	O
improving	O
function	O
in	O
the	O
intermediate	O
-	O
term	O
(	O
12	O
weeks	O
)	O
and	O
long	O
-	O
term	O
(	O
half	O
year	O
and	O
one	O
year	O
)	O
.	O

Considering	O
the	O
long	O
-	O
term	O
effectiveness	O
of	O
platelet	B:C0370220
rich	I:C0370220
plasma	I:C0370220
,	O
we	O
recommend	O
platelet	O
rich	I:C0370220
plasma	I:C0370220
as	O
the	O
preferred	O
option	O
for	O
Lateral	O
epicondylitis	I:C0039516
.	O

Considering	O
the	O
long	O
-	O
term	O
effectiveness	O
of	O
platelet	O
rich	I:C0370220
plasma	I:C0370220
,	O
we	O
recommend	O
platelet	B:C0370220
rich	I:C0370220
plasma	I:C0370220
as	O
the	O
preferred	O
option	O
for	O
Lateral	O
epicondylitis	I:C0039516
.	O

Considering	O
the	O
long	O
-	O
term	O
effectiveness	O
of	O
platelet	O
rich	I:C0370220
plasma	I:C0370220
,	O
we	O
recommend	O
platelet	O
rich	I:C0370220
plasma	I:C0370220
as	O
the	O
preferred	O
option	O
for	O
Lateral	B:C0039516
epicondylitis	I:C0039516
.	O

